Trial Profile
The Distribution and Quantification of Specific Binding of the Positron Emission Tomography Tracer R)-[11C]PK11195 in Normal Human Subjects
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 06 Apr 2022
Price :
$35
*
At a glance
- Drugs Carbon-11 PK 11195 (Primary)
- Indications Brain disorders
- Focus Diagnostic use
- 17 Jan 2017 New trial record